Thai Drug Administration: Buy Chinese medicines such as Lianhua Qing Plague to recognize regular channels

The Thai Food and Drug Administration (hereinafter referred to as the Pharmaceutical Supervision Bureau) issued a reminder that consumers carefully checked product information such as the registration number and efficacy of the drug supervision bureau when purchasing drugs, and selected the Thai Drug Administration such as "Lianhua Qing Plague" to obtain the Thai Drug Administration Chinese medicine brand with legal registration batch number.

Recently, the Thai Drug Administration is popularizing the people's knowledge of food and drug safety to the public. It is recommended that when purchasing drugs, it can check product information through the official website of the Drug Administration and the APP platform. Dr. Surawa, Deputy Secretary -General of the Thai Drug Administration, said that Chinese herbal medicines such as the "Lianhua Qing Plague Capsule" of Chinese herbal medicines have been certified by the Pharmaceutical Supervision Bureau in March 2020. Heat, muscle soreness, nasal congestion, cough, sore throat, headache and other symptoms caused by cold and flu.

According to reports, Lianhua Qing Plague is a patent traditional Chinese medicine for preventing colds and influenza in the production of Ling Pharmaceuticals, and it is also a representative of the prevention and treatment of respiratory diseases in traditional Chinese medicine. The drug uses the theory of traditional Chinese medicine to explore the laws of temperature sensing and plague transmission and treatment. Its group learns the experience of preventing and treatment of plague in 2000 in 2000, and integrates the essence of medicine for the famous medicine of the Three Dynasties. Pulmonary fever.

At present, the drug has been approved for listing in more than 20 countries and regions including Brazil, Indonesia, Kuwait, and Cambodia. It has been approved for new crown indications in Kuwait and was selected as the whitening list of anti -epidemic drugs in the Ministry of Health of Uzbekistan. In Thailand and Cambodia, Lianhua Qingjuan was allowed to enter a designated hospital for new crown pneumonia for treatment of local patients. In July 2021, Lianhua Qing Plague was selected as a home treatment plan for patients with new crown pneumonia patients released by the Ministry of Health of Cambodia.

As a traditional Chinese medicine brand registered in Thailand's FDA, Thai people have increased significantly during the epidemic period. Earlier, Ridge Pharmaceutical and its only legal imported Shang Enwei Group Co., Ltd. in Thailand had issued a joint statement that the Lianhua Qingjian capsule packaging and inner packaged aluminum foil in Thailand were printed on the trademarks of Yiling and ENWEI and related Thai descriptions. Essence

Editor in charge: Wu Yinglan

- END -